Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
8.1%
% of IHE's 38 holdings also in OZEM
13.0%
% of OZEM's 23 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.2% | 14.2% | 14.2% |
|
PFIZER INC | 4.0% | 3.0% | 3.0% |
|
CORCEPT THERAPEUTICS INC | 2.0% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 22.2% |
|
BRISTOL-MYERS SQUIBB CO | 5.5% |
|
VIATRIS, INC. | 5.4% |
|
ELI LILLY & CO | 5.1% |
|
CATALENT INC | 4.4% |
|
ZOETIS INC | 4.4% |
|
ROYALTY PHARMA PLC CLASS A | 4.1% |
|
MERCK & CO. INC. | 4.0% |
|
INTRA-CELLULAR THERAPIES INC | 3.4% |
 |
JAZZ PHARMACEUTICALS PLC | 3.1% |
IHE Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.9% |
 |
ROCHE HOLDING LTD | -4.9% |
|
ZEALAND PHARMA A/S | -4.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ALTIMMUNE, INC. | -4.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.3% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
|
AMGEN INC | -3.2% |
|
SCHOLAR ROCK HOLDING CORP. | -2.7% |